Table of Contents

company-logo

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. The company offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; Cardio'B, a portable device to transmit a 12-lead ECG; and Cardio Beeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. It also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote electronic handheld device to test the working of lungs; and TelePulse Oximeter, an electronic handheld diagnostic device to measure the saturation level of oxygen in blood, as well as pulse rate. The company offers its telemedicine services and devices to subscribers using telephonic and internet communication technology. It serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. The company has a collaboration agreement with Mayo Clinic to evaluate the incidence of emergency department visits, re-hospitalizations, and major adverse cardiovascular events over a period of 90 days after first hospitalization for a heart attack for patients using SmartHeart FDA approved 12 lead ECG; and collaboration agreement with the Hebrew University of Jerusalem and the Hadassah Medical Center to develop an artificial intelligence tool for predicting future life-threatening cardiac events based on 12 Lead ECG monitoring. SHL Telemedicine Ltd. was founded in 1987 and is headquartered in Tel Aviv, Israel.

SHL Telemedicine Dividend Announcement

• SHL Telemedicine does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on SHL Telemedicine dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

SHL Telemedicine Dividend History

SHL Telemedicine Dividend Yield

SHL Telemedicine current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing SHL Telemedicine stock? Use our calculator to estimate your expected dividend yield:

SHL Telemedicine Financial Ratios

P/E ratio-5.98
PEG ratio-0.04
P/B ratio0.78
ROE-12.55%
Payout ratio0.00%
Current ratio2.17
Quick ratio1.98
Cash Ratio0.71

SHL Telemedicine Dividend FAQ

Does SHL Telemedicine stock pay dividends?
SHL Telemedicine does not currently pay dividends to its shareholders.
Has SHL Telemedicine ever paid a dividend?
No, SHL Telemedicine has no a history of paying dividends to its shareholders. SHL Telemedicine is not known for its dividend payments.
Why doesn't SHL Telemedicine pay dividends?
There are several potential reasons why SHL Telemedicine would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will SHL Telemedicine ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While SHL Telemedicine has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is SHL Telemedicine a dividend aristocrat?
SHL Telemedicine is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is SHL Telemedicine a dividend king?
SHL Telemedicine is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is SHL Telemedicine a dividend stock?
No, SHL Telemedicine is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy SHL Telemedicine stocks?
To buy SHL Telemedicine you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy SHL Telemedicine stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.